Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation

NCT05351333 is registered in ClinicalTrials.gov with Spaulding Rehabilitation Hospital as lead sponsor.

NCT NCT05351333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05351333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation
Lead sponsor
Spaulding Rehabilitation Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 3, 2022
Completion date
July 31, 2026
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns, polytrauma, spinal cord injuries